Characteristics of Patients With Thymoma in Chulalongkorn Hospital

This study has been completed.
Sponsor:
Information provided by:
Chulalongkorn University
ClinicalTrials.gov Identifier:
NCT01123590
First received: May 12, 2010
Last updated: November 21, 2010
Last verified: November 2010
  Purpose

The purpose of this study is to study characteristics of patients with thymoma in Chulalongkorn hospital between 2003-2007.


Condition
Thymoma Staging
Clinical Presentations
Associated Disorders
Laboratory Findings

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Retrospective
Official Title: Characteristics of Patients With Thymoma Undergone Thymectomy in Chulalongkorn Hospital Between 2003-2007

Resource links provided by NLM:


Further study details as provided by Chulalongkorn University:

Primary Outcome Measures:
  • Thymoma staging and clinical manifestations [ Time Frame: 5 years ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Associated diseases and laboratory findings Immunological data [ Time Frame: 4 months ] [ Designated as safety issue: No ]

Biospecimen Retention:   Samples Without DNA

PBMC


Enrollment: 50
Study Start Date: November 2009
Study Completion Date: October 2010
Primary Completion Date: April 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts
Thymoma
Patients with thymoma
Control
Normal controls

Detailed Description:

To study characteristics of patients with thymoma undergone thymectomy in Chulalongkorn hospital between 2003-2007 in terms of clinical manifestations, associated diseases, and laboratory findings.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Patients with thymoma undergone thymectomy in Chulalongkorn hospital between 2003-2007

Criteria

Inclusion Criteria:

  • Patients with histocytological proved thymoma undergone thymectomy in Chulalongkorn hospital between 2003-2007

Exclusion Criteria:

  • None
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01123590

Locations
Thailand
Faculty of Medicine, Chulalongkorn University
Bangkok, Thailand, 10330
Sponsors and Collaborators
Chulalongkorn University
Investigators
Principal Investigator: Jettanong Klaewsongkram, MD Chulalongkorn University
  More Information

No publications provided by Chulalongkorn University

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Jettanong Klaewsongkram, Chulalongkorn University
ClinicalTrials.gov Identifier: NCT01123590     History of Changes
Other Study ID Numbers: Chula-ARC 003/09
Study First Received: May 12, 2010
Last Updated: November 21, 2010
Health Authority: Thailand: Ethical Committee

Keywords provided by Chulalongkorn University:
Thymoma
Autoimmune diseases
Immunodeficiency

Additional relevant MeSH terms:
Thymoma
Thymus Neoplasms
Neoplasms, Complex and Mixed
Neoplasms by Histologic Type
Neoplasms
Thoracic Neoplasms
Neoplasms by Site
Lymphatic Diseases

ClinicalTrials.gov processed this record on September 14, 2014